View in EDS HTML Full Text PDF Full Text

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Saved in:

Bibliographic Details
Title:	Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Authors:	Tsuji, Keiji¹, Kurosaki, Masayuki², Itakura, Jun², Mori, Nami¹, Takaki, Shintaro¹, Hasebe, Chitomi³, Akahane, Takehiro⁴, Joko, Kouji⁵, Yagisawa, Hitoshi⁶, Takezawa, Jirou⁷, Nakata, Ryou⁸, Kusakabe, Atsunori⁹, Kojima, Yuji¹⁰, Kimura, Hiroyuki¹¹, Tamada, Takashi¹², Kobashi, Haruhiko¹³, Mitsuda, Akeri¹⁴, Kondou, Masahiko¹⁵, Ogawa, Chikara¹⁶, Uchida, Yasushi¹⁷
Source:	Journal of Gastroenterology. Oct2018, Vol. 53 Issue 10, p1142-1150. 9p. 3 Charts, 4 Graphs.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!